Management of Complications Associated with Partially Covered Biliary Metal Stents
First Online: 07 March 2009 Received: 11 December 2008 Accepted: 03 February 2009 DOI:
10.1007/s10620-009-0756-x Cite this article as: Ho, H., Mahajan, A., Gosain, S. et al. Dig Dis Sci (2010) 55: 516. doi:10.1007/s10620-009-0756-x Abstract Background Partially covered metal stents (PCMS) have been increasingly used for both malignant and benign biliary indications. This study reports their complications and subsequent management. Methods Over 5 years, all patients receiving biliary PCMS were followed prospectively until stent-related dysfunction or death. Data were analyzed for the following variables: primary disease, time until revision, and type and reason for revision. Results PCMS were placed in 396 patients (247 with malignant biliary strictures and 149 with benign biliary disease). Complications were observed in 70 patients (18%), occurring a mean time following placement of 159 days. Duodenal migration occurred in 27 cases (6.8%), while proximal migration occurred in 9 cases (2.3%). Cholecystitis was documented in 13 cases (3.3%). There were six cases of stent occlusion due to debris or sludge (1.6%), four cases of pancreatitis (1%), four cases of tumor overgrowth (1%), three cases of benign stenosis in the uncovered portion of the PCMS (0.8%), two cases of abdominal pain (0.5%), one case of an infected biloma (0.3%), and one case of a liver abscess (0.3%). Conclusions Major complications associated with PCMS placement include migration and cholecystitis. Their management includes endoscopic revision, cholecystectomy, and gallbladder drainage. Further improvements in the structure and composition of PCMS may prevent these complications. Keywords ERCP: Endoscopic retrograde cholangiopancreatography SEMS: Self-expanding metal stent PCMS: Partially covered self-expanding metal stent References
Soehendra N, Reynders-Frederix V. Palliative bile duct drainage—a new endoscopic method of introducing a transpapillary drain.
Levy MJ, Baron TH, Gostout CJ, Petersen BT, Farnell MB. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach.
Clin Gastroenterol and Hepatol
Knyrim K, Wagner HJ, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.
Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct.
Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.
Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.
Am J Gastroenterol
Shim CS, Lee YH, Cho YD, et al. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction.
Thurnher SA, Lammer J, Thurnher MM, Winkelbauer F, Graf O, Wildling R. Covered self-expanding transhepatic biliary stents: clinical pilot study.
Cardiovasc Intervent Radiol
Petersen BT. SEMS removal: salvage technique or new paradigms.
Kahaleh M, Tokar J, Le T, Yeaton P. Removal of self-expandable metallic Wallstents.
Familiari P, Bulajic M, Mutignani M, et al. Endoscopic removal of malfunctioning biliary self-expandable metallic stents.
Kahaleh M, Brock A, Conaway MR, et al. Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis.
Mullen JT, Lee JH, Gomez HF, et al. Pancreaticoduodenectomy after placement of endobiliary metal stents.
J Gastrointest Surg
Carr-Locke DL. Metal stents for distal biliary malignancy: have we got you covered?
Wamsteker EJ, Elta GH. Migration of covered biliary self-expanding metallic stents in two patients with malignant biliary obstruction.
Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction.
Kahaleh M, Tokar J, Conaway MR, et al. Efficacy and complications of covered Wallstents in malignant distal biliary obstruction.
Suk KT, Kim HS, Kim JW, et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction.
Isayama H, Kawabe T, Nakai Y, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction.
Clin Gastroenterol Hepatol
Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract.
N Engl J Med
Born P, Neuhaus H, Rosch T, et al. Initial experience with a new, partially covered Wallstent for malignant biliary obstruction.
Nakamura T, Hirai R, Kitagawa M, et al. Treatment of common bile duct obstruction by pancreatic cancer using various stents: single-center experience.
Cardiovasc Intervent Radiol
Nakai Y, Isayama H, Komatsu Y, et al. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction.
Isayama H, Komatsu Y, Tsujino T, et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction.
Cantu P, Hookey LC, Morales A, Le Moine O, Deviere J. The treatment of patients with symptomatic common bile duct stenosis secondary to chronic pancreatitis using partially covered metal stents: a pilot study.
Bezzi M, Zolovkins A, Cantisani V, et al. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction.
J Vasc Interv Radiol
Matsushita M, Takakuwa H, Nishio A, Kido M, Shimeno N. Open-biopsy-forceps technique for endoscopic removal of distally migrated and impacted biliary metallic stents.
Minami A, Fujita R. A new technique for removal of bile duct stones with an expandable metallic stent.
Miyayama S, Matsui O, Terayama N, Tatsu H, Yamamoto T, Takashima T. Covered gianturco stents for malignant biliary obstruction: preliminary clinical evaluation.
J Vasc Interv Radiol
Sung JY, Shaffer EA, Costerton JW. Antibacterial activity of bile salts against common biliary pathogens Effects of hydrophobicity of the molecule and in the presence of phospholipids.
Dig Dis Sci
Coene PP, Groen AK, Cheng J, Out MM, Tytgat GN, Huibregtse K. Clogging of biliary endoprostheses: a new perspective.
Rossi P, Bezzi M, Salvatori FM, Panzetti C, Rossi M, Pavia G. Clinical experience with covered wallstents for biliary malignancies: 23-month follow-up.
Cardiovasc Intervent Radiol
Schoder M, Rossi P, Uflacker R, et al. Malignant biliary obstruction: treatment with ePTFE-FEP-covered endoprostheses initial technical and clinical experiences in a multicenter trial.
Hausegger KA, Thurnher S, Bodendorfer G, et al. Treatment of malignant biliary obstruction with polyurethane-covered Wallstents.
AJR Am J Roentgenol
Ainley CC, Williams SJ, Smith AC, Hatfield AR, Russell RC, Lees WR. Gallbladder sepsis after stent insertion for bile duct obstruction: management by percutaneous cholecystostomy.
Br J Surg
Gregg JA, De Girolami P, Carr-Locke DL. Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct.
Am J Surg
Parker HW, Geenen JE, Bjork JT, Stewart ET. A prospective analysis of fever and bactermia following ERCP.
Deviere J, Motte S, Dumonceau JM, Serruys E, Thys JP, Cremer M. Septicemia after endoscopic retrograde cholangiopancreatography.
CrossRef PubMed Copyright information
© Springer Science+Business Media, LLC 2009